7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Femur Head Necrosis D005271 5 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Foreign-Body Reaction D005549 10 associated lipids
Gingival Recession D005889 2 associated lipids
Glioma D005910 112 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Graves Disease D006111 6 associated lipids
Heart Failure D006333 36 associated lipids
Heart Valve Diseases D006349 4 associated lipids
Hemarthrosis D006395 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Lin DL et al. Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro. 2001 Prostate pmid:11351351
Sparks AB et al. Mutation screening of the TNFRSF11A gene encoding receptor activator of NF kappa B (RANK) in familial and sporadic Paget's disease of bone and osteosarcoma. 2001 Calcif. Tissue Int. pmid:11351498
Disthabanchong S and González EA Regulation of bone cell development and function: implication for renal osteodystrophy. 2001 J. Investig. Med. pmid:11352181
Kotake S et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. 2001 Arthritis Rheum. pmid:11352231
Saika M et al. 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. 2001 Endocrinology pmid:11356664
Luger NM et al. Osteoprotegerin diminishes advanced bone cancer pain. 2001 Cancer Res. pmid:11358823
Goltzman D Osteolysis and cancer. 2001 J. Clin. Invest. pmid:11375409
Zhang J et al. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. 2001 J. Clin. Invest. pmid:11375413
Kostenuik PJ and Shalhoub V Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. 2001 Curr. Pharm. Des. pmid:11375772
Kanzaki H et al. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. 2001 J. Dent. Res. pmid:11379890

Table of Content